WALDW
Waldencast plc
NASDAQ · Technology · Software - Application · US
$0.01
+102.86%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.01
From 52W high−89.24%
Volume3.66M
Market cap$798572.78
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataSep 18, 2026
Open
$0.01
From 52W high
−89.24%
Volume
3.66M
Market cap
$798572.78
ValuationView details →
P/E (Fwd)
0.2x
EV/EBITDA
−1.0x
P/E (TTM)
—
RSI (14)
28.0
MomentumView details →
1D Return
+102.86%
YTD Return
−85.50%
Similar companies
Latest newsMore news →
Waldencast plc's board approved the voluntary delisting of its Class A Ordinary Shares and Warrants from Nasdaq and deregistration under the Exchange Act, with a Form 25 expected to be filed with the SEC on or about September 24, 2026.6d agoWaldencast completed the sale of its Obagi Medical business to Bridgepoint for up to $460 million.52d agoWaldencast Plc filed a lawsuit in Delaware's Chancery Court against former Obagi CEO Jaime Castle and former parent Cedarwalk Skincare Ltd., alleging a channel-stuffing scheme that inflated Obagi's earnings by $50 million and caused Waldencast to overpay by hundreds of millions of dollars.55d ago